Clinical audit of patients with cervical cancer in Slovenia. Data analysis from 2003-2006

Purpose of investigation: From 2003 to 2006 the data on Slovenian cervical cancer patients who regularly attended a gynecologist were gathered. Data were analyzed in order to improve the efficiency of the cervical cancer screening program. Methods: Data on all patients newly diagnosed with cervical cancer were collected at three central clinics in Slovenia. The results are a presentation and comparison of detailed information on some characteristics of cervical cancer patients of the group that regularly visited a gynecologist and of the other group who did not. Data were processed by descriptive epidemiological methods. Mantel-Haenzel chi2 and Fisher's p tests were used to evaluate statistical significance. Results: On average, 55% of patients with cervical cancer underwent a gynecological examination five years before the diagnosis. The patients who regularly attended their gynecologist were, in all age groups, statistically significantly younger, the stage of cervical cancer at diagnosis was statistically significantly lower (p = 0.01) and were, in statistically significantly higher percentage, treated surgically (p < 0.01). From 2003 to 2006, each patient had on average five examinations at her gynecologist within the period of five years to six months before the diagnosis of cervical cancer. The average number of collected smear samples was 3.2. Conclusion: From the results of our analysis, it may be concluded that improvements are needed in Slovenia in the field of screening for and early detection of cervical cancer.

Clinical audit; Cervical cancer; State screening program; Premalignant cervical disease

[1] Van Ballegooijen M., van den Akker-van Marle E., Patnick J., Lynge E., Arbyn M., Anttila A. et al.: “Overview of important cervical cancer screening process values in the European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness”. Eur. J. Cancer, 2000, 36, 2177.

[2] Coleman D., Day N.E., Douglas D., Farmerg E., Lynge E., Philip J. et al.: “European guidelines for quality assurance in cervical cancer screening”. Eur. J. Cancer, 1993, 29A (suppl. 4), S1.

[3] Commission of the European Communities: proposal for a Council recommendation on Cancer Screening. 2003/0093 (CNS). Brussels, 5th May, 2003; and the Council Recommendation of December 2003 on cancer screening 2003/87 EC.

[4] Audit of invasive cervical cancer. NHSCSP Publication No 28, December 2006.

[5] Ursˇicˇ Vrsˇcˇaj M., Primic Zˇakelj M., Kirar Fazarinc I.: “Epidemiologija raka maternicˇnega vratu v Sloveniji in v svetu ter nacionalni program ZORA. Mozˇina D (ured.): Zgodnja detekcija raka maternicˇnega vratu in kolposkopski tecˇaj. Prakticˇna kolposkopija in ambulantno zdravljenje prekanceroze, Ljubljana 2003. Zbornik predavanj. Ljubljana, Klinicˇni center - Ginekolosˇka klinika - Zdruzˇenje za ginekolosˇko onkologijo, kolposkopijo in cervikalno patologijo 2003, 92.

[6] Primic Zˇakelj M., Bracˇko M., Hocˇevar M., Pompe-Kirn V., Strojan P., Zadnik V. et al.: “Cancer incidence in Slovenia 2003”. Ljubljana: Onkolosˇki insˇtitut, Register raka za Slovenijo, 2006, 1.

[7] Ursˇicˇ Vrsˇcˇaj M., Rakar S., Mozˇina A., Takacˇ I., Sˇubic Z., Kodricˇ T., Smrkolj S.: “Clinical audit of patients with cervical cancer in Slovenia - Data analysis for the year 2003”. Eur. J. Gynaecol. Oncol., 2005, 26, 537.

[8] Nygard F.F., Nygard M., Skare G.B., Thoresen S.O.: “Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated cervical Cancer Screening program”. Cancer Causes Control, 2005, 16, 463.

[9] Stuart G.C.E., McGregor E., Duggan M.A., Nation J.G.: “Review of the screening history of Alberta women with invasive cervical cancer”. Can Med. Assoc. J., 1997, 157, 513.

[10] Mitchell H., Medley G., Gules G.: “Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s”. Br. Med. J., 1990, 300, 1622.

[11] Ursˇicˇ Vrsˇcˇaj M., Rakar S., Kovacˇicˇ J., Kralj B., Mozˇina A.: “Priporoc ˇila za odkrivanje, zdravljenje in nadzor bolnic s predrakavimi spremembami maternicˇnega vratu”. Zdravnisˇka zbornica Slovenije, 2000.

[12] Leman R.F., Espey D., Cobb N.: “Invasive cervical cancer among American Indian women in the Northern Plains, 1994-1998: Incidence, mortality, and missed opportunities”. Public Health Reports, 2005, 120, 283.

[13] Paraskevaidis E., Arbyn M., Sotiriadis A., Diakomanolis E., Martin-Hirsch P., Koliopoulos G. et al.: “The role of HPV DNA testing in the follow-up period after treatment for CIN: a systemic review of the literature”. Cancer Treat. Rev., 2004, 30 (suppl. 2), 205.

[14] Ursˇicˇ Vrsˇcˇaj M.: “Pomen HPV 16 in 18 pri odkrivanju zgodnjega raka maternicˇnega vratu (RMV)”. Doktorsko delo, Medicinska fakulteta. Ljubljana, 1995.

[15] Arbyn M., Buntix F., Van Ranst M., Paraskevaidis E., Martin- Hirsch P., Dillner J. et al.: “Virologic versus cytologic triage of women with equivocal PAP smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia”. J. Natl Cancer Inst., 2004, 96 (suppl. 4), 280.

[16] Priest P., Sadler L., Peters J., Crengle S., Bethwaite P., Medley G., Jackson R.: “Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading”. Br. J. Obstet. Gynecol., 2007, 114, 398.

[17] Ursˇicˇ Vrsˇcˇaj M., Mozˇina A., Rakar S.: “Predlogi za standarde in kazalce kakovosti pri kolposkopiji, zdravljenju in nadzoru bolnics predrakavimi spremembami maternicˇnega vratu. Mozˇina A (ured): Zgodnja detekcija raka maternicˇnega vratu in kolposkopski tecˇaj”. Prakticˇna kolposkopija in ambulantno zdravljenje prekanceroz, Ljubljana 2003. Zbornik predavanj. Ljubljana, Klinicˇni center – Ginekolosˇka klinika – Zdruzˇenje za ginekolosˇko onkologijo, kolposkopijo in cervikalno patologijo, 2003, 98.